Suchergebnisse - "Cheng, Shu"

PubPharm (1.604)

71

Lipidomic analysis identifies long-chain acylcarnitine as a target for ischemic stroke

enthalten in: Journal of advanced research | 2023

von Huang, X. | Li, L. | Jiang, R. | +11

72

Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma : results of a randomized, phase III, non-inferiority trial

enthalten in: Cancer communications (London, England) | 2023

von Shi, Q. | He, Y. | Yi, H. | +11

73

Identification of the LNC02362–EFNA5 axis as a Potential Prognosis Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis

enthalten in: ResearchSquare.com | 2023

von Liu, Y. | Li, X. | Li, S. | +12

74

Synbiotic composition and application thereof

enthalten in: Europäisches Patentamt | 2023

von DAI XIAOSHUANG | LIU XUEBO | SHI RENJIE | +4

75

Resolvin D1 reprograms energy metabolism to promote microglia to phagocytize neutrophils after ischemic stroke

enthalten in: Cell reports | 2023

von Li, L. | Cheng, S. | Sun, Y. | +7

76

Improve learning retention, self-efficacy, learning attitude and problem-solving skills through e-books based on sequential multi-level prompting strategies

enthalten in: Education and information technologies | 2023

von Lee, Y. | Chen, P. | Cheng, S.

77

Longitudinal neutralizing antibody responses after SARS-CoV-2 infection : A convalescent cohort study in Taiwan

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2023

von Huang, Y. | Hsu, F. | Wu, J. | +17

78

Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients

enthalten in: Microbiology spectrum | 2023

von Huang, Y. | Cheng, C. | Sun, H. | +14

79

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

enthalten in: BMC cancer | 2023

von Zhu, H. | Feng, J. | Xiang, Y. | +7

80

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

enthalten in: BMC cancer | 2023

von Zhu, H. | Feng, J. | Xiang, Y. | +7